Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 13.33
-0.08 (-0.60%)
Aug 14, 2026, 3:00 PM CST
Zhejiang Medicine Market Cap
Zhejiang Medicine has a market cap or net worth of 12.64 billion as of August 14, 2026. Its market cap has decreased by -16.99% in one year.
Market Cap
12.64B
Enterprise Value
10.48B
Revenue
8.82B
Ranking
n/a
PE Ratio
17.07
Stock Price
13.33
ChartMarket Cap Chart
Since January 2, 2001, Zhejiang Medicine's market cap has increased from 5.53B to 12.64B, an increase of 128.38%. That is a compound annual growth rate of 3.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 12.64B | -3.82% |
| Dec 31, 2025 | 13.14B | -13.86% |
| Dec 31, 2024 | 15.25B | 48.35% |
| Dec 29, 2023 | 10.28B | -8.23% |
| Dec 30, 2022 | 11.20B | -31.56% |
| Dec 31, 2021 | 16.37B | 25.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Chipscreen Biosciences | 13.66B |
| Wedge Industrial | 13.10B |
| Nanjing King-Friend Biochemical Pharmaceutical | 13.04B |
| Beijing Aosaikang Pharmaceutical | 12.92B |
| PharmaBlock Sciences (Nanjing) | 12.76B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.54B |
| Guobang Pharma | 11.99B |
| Zhejiang CONBA Pharmaceutical | 11.87B |